End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 EUR | -.--% | -.--% | -.--% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-1.17% | 104B | |
+2.87% | 97.47B | |
+4.40% | 22.25B | |
-14.77% | 21.68B | |
-8.65% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- OVXA Stock
- OVXA Stock
- News Ovoca Bio plc
- Ovoca Bio's Russian Units Not Subject To Sanctions, Shares Up 44%